Annual CFF
$5.86 M
+$2.61 M+80.22%
December 1, 2023
Summary
- As of February 7, 2025, ADXN annual cash flow from financing activities is $5.86 million, with the most recent change of +$2.61 million (+80.22%) on December 1, 2023.
- During the last 3 years, ADXN annual CFF has risen by +$5.81 million (+11744.44%).
- ADXN annual CFF is now -94.69% below its all-time high of $110.34 million, reached on December 31, 2007.
Performance
ADXN Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$4900.00
+$74.70 K+107.02%
September 1, 2024
Summary
- As of February 7, 2025, ADXN quarterly cash flow from financing activities is $4900.00, with the most recent change of +$74.70 thousand (+107.02%) on September 1, 2024.
- Over the past year, ADXN quarterly CFF has increased by +$110.10 thousand (+104.66%).
- ADXN quarterly CFF is now -99.95% below its all-time high of $9.72 million, reached on March 31, 2021.
Performance
ADXN Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
-$40.90 K
+$110.10 K+72.91%
September 1, 2024
Summary
- As of February 7, 2025, ADXN TTM cash flow from financing activities is -$40.90 thousand, with the most recent change of +$110.10 thousand (+72.91%) on September 1, 2024.
- Over the past year, ADXN TTM CFF has dropped by -$5.93 million (-100.69%).
- ADXN TTM CFF is now -100.23% below its all-time high of $17.95 million, reached on December 31, 2021.
Performance
ADXN TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
ADXN Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +80.2% | +104.7% | -100.7% |
| 3 y3 years | +10000.0% | -100.0% | -100.2% |
| 5 y5 years | -84.7% | +105.3% | +91.2% |
ADXN Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -67.3% | +80.2% | -100.0% | +100.6% | -100.2% | +72.9% |
| 5 y | 5-year | -67.3% | +1356.3% | -100.0% | +100.6% | -100.2% | +92.8% |
| alltime | all time | -94.7% | +1356.3% | -100.0% | +100.6% | -100.2% | +92.8% |
Addex Therapeutics Ltd Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $4900.00(-107.0%) | -$40.90 K(-72.9%) |
| Jun 2024 | - | -$69.80 K(-137.1%) | -$151.00 K(-103.1%) |
| Mar 2024 | - | $188.30 K(-214.6%) | $4.94 M(-15.7%) |
| Dec 2023 | $5.86 M(+80.2%) | -$164.30 K(+56.2%) | $5.86 M(-0.5%) |
| Sep 2023 | - | -$105.20 K(-102.1%) | $5.89 M(-43.0%) |
| Jun 2023 | - | $5.02 M(+352.3%) | $10.33 M(+99.9%) |
| Mar 2023 | - | $1.11 M(-927.4%) | $5.17 M(+58.9%) |
| Dec 2022 | $3.25 M(-81.9%) | -$134.20 K(-103.1%) | $3.25 M(-73.7%) |
| Sep 2022 | - | $4.34 M(-3155.1%) | $12.35 M(+57.4%) |
| Jun 2022 | - | -$141.90 K(-82.4%) | $7.85 M(+5.7%) |
| Mar 2022 | - | -$805.90 K(-109.0%) | $7.42 M(-58.7%) |
| Dec 2021 | $17.95 M(>+9900.0%) | $8.96 M(-5348.7%) | $17.95 M(+88.6%) |
| Sep 2021 | - | -$170.80 K(-69.9%) | $9.51 M(-0.5%) |
| Jun 2021 | - | -$567.30 K(-105.8%) | $9.56 M(-4.2%) |
| Mar 2021 | - | $9.72 M(+1728.8%) | $9.99 M(>+9900.0%) |
| Dec 2020 | $49.50 K | $531.50 K(-541.8%) | $49.50 K(-108.7%) |
| Sep 2020 | - | -$120.30 K(-16.9%) | -$571.00 K(+5.1%) |
| Jun 2020 | - | -$144.70 K(-33.3%) | -$543.40 K(-4.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$217.00 K(+143.8%) | -$570.40 K(+22.2%) |
| Dec 2019 | -$466.70 K(-101.2%) | -$89.00 K(-4.0%) | -$466.70 K(+23.6%) |
| Sep 2019 | - | -$92.70 K(-46.0%) | -$377.70 K(+32.5%) |
| Jun 2019 | - | -$171.70 K(+51.5%) | -$285.00 K(+151.5%) |
| Mar 2019 | - | -$113.30 K | -$113.30 K |
| Dec 2018 | $38.22 M(+1022.1%) | - | - |
| Dec 2017 | $3.41 M(+124.9%) | - | - |
| Dec 2016 | $1.51 M(-50.3%) | - | - |
| Dec 2015 | $3.04 M(+488.7%) | - | - |
| Dec 2014 | $517.20 K(-84.9%) | - | - |
| Dec 2013 | $3.44 M(-63.8%) | - | - |
| Dec 2012 | $9.49 M(-4677.0%) | - | - |
| Dec 2011 | -$207.40 K(-101.1%) | - | - |
| Dec 2010 | $18.82 M(+6366.5%) | - | - |
| Dec 2009 | $291.10 K(-407.4%) | - | - |
| Dec 2008 | -$94.70 K(-100.1%) | - | - |
| Dec 2007 | $110.34 M(+248.7%) | - | - |
| Dec 2006 | $31.64 M | - | - |
FAQ
- What is Addex Therapeutics Ltd annual cash flow from financing activities?
- What is the all time high annual CFF for Addex Therapeutics Ltd?
- What is Addex Therapeutics Ltd annual CFF year-on-year change?
- What is Addex Therapeutics Ltd quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Addex Therapeutics Ltd?
- What is Addex Therapeutics Ltd quarterly CFF year-on-year change?
- What is Addex Therapeutics Ltd TTM cash flow from financing activities?
- What is the all time high TTM CFF for Addex Therapeutics Ltd?
- What is Addex Therapeutics Ltd TTM CFF year-on-year change?
What is Addex Therapeutics Ltd annual cash flow from financing activities?
The current annual CFF of ADXN is $5.86 M
What is the all time high annual CFF for Addex Therapeutics Ltd?
Addex Therapeutics Ltd all-time high annual cash flow from financing activities is $110.34 M
What is Addex Therapeutics Ltd annual CFF year-on-year change?
Over the past year, ADXN annual cash flow from financing activities has changed by +$2.61 M (+80.22%)
What is Addex Therapeutics Ltd quarterly cash flow from financing activities?
The current quarterly CFF of ADXN is $4900.00
What is the all time high quarterly CFF for Addex Therapeutics Ltd?
Addex Therapeutics Ltd all-time high quarterly cash flow from financing activities is $9.72 M
What is Addex Therapeutics Ltd quarterly CFF year-on-year change?
Over the past year, ADXN quarterly cash flow from financing activities has changed by +$110.10 K (+104.66%)
What is Addex Therapeutics Ltd TTM cash flow from financing activities?
The current TTM CFF of ADXN is -$40.90 K
What is the all time high TTM CFF for Addex Therapeutics Ltd?
Addex Therapeutics Ltd all-time high TTM cash flow from financing activities is $17.95 M
What is Addex Therapeutics Ltd TTM CFF year-on-year change?
Over the past year, ADXN TTM cash flow from financing activities has changed by -$5.93 M (-100.69%)